{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:15:13Z","timestamp":1791231313886,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T00:00:00Z","timestamp":1163462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1245\/s10434-006-9196-4","type":"journal-article","created":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T00:50:12Z","timestamp":1163465412000},"page":"869-884","source":"Crossref","is-referenced-by-count":41,"title":["A phase-I Trial Using a Universal GM-CSF-producing and CD40L-expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-based Vaccines for Cancer Patients with Stage IV disease"],"prefix":"10.1245","volume":"14","author":[{"given":"Sophie","family":"Dessureault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Noyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sotomayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Antonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,11,14]]},"reference":[{"issue":"Suppl 3","key":"9196_CR1","first-page":"S200","volume":"6","author":"SA Rosenberg","year":"2000","unstructured":"Rosenberg SA. Identification of cancer antigens: impact on development of cancer immunotherapies. Cancer J 2000; 6(Suppl 3):S200\u2013S207","journal-title":"Cancer J"},{"key":"9196_CR2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.190.5.705","volume":"190","author":"MJ Pittet","year":"1999","unstructured":"Pittet MJ, Valmori D, Dunbar PR et al. High frequencies of naive Melan-A\/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med 1999; 190:705\u2013715","journal-title":"J Exp Med"},{"key":"9196_CR3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.190.5.651","volume":"190","author":"A Anichini","year":"1999","unstructured":"Anichini A, Molla A, Mortarini R et al. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions. J Exp Med 1999; 190:651\u2013667","journal-title":"J Exp Med"},{"key":"9196_CR4","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1073\/pnas.97.9.4760","volume":"97","author":"E Jager","year":"2000","unstructured":"Jager E, Nagata Y, Gnjatic S et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. PNAS (USA) 2000; 97:4760\u20134765","journal-title":"PNAS (USA)"},{"key":"9196_CR5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jss.2004.11.036","volume":"125","author":"S Dessureault","year":"2005","unstructured":"Dessureault S, Alsarraj M, McCarthy S et al. A GM-CSF\/CD40L Producing Cell Augments Anti-tumor T Cell Responses. J Surg Res 2005; 125:173\u2013181","journal-title":"J Surg Res"},{"key":"9196_CR6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/10503","volume":"5","author":"EM Sotomayor","year":"1999","unstructured":"Sotomayor EM, Borrello I, Tubb E et al. Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nat Med 1999; 5:780\u2013787","journal-title":"Nat Med"},{"key":"9196_CR7","first-page":"4485","volume":"60","author":"P Brossart","year":"2000","unstructured":"Brossart P, Zobywalski A, Grunebach F et al. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Cancer Res 2000; 60:4485\u20134492","journal-title":"Cancer Res"},{"key":"9196_CR8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1054\/bjoc.2000.1289","volume":"83","author":"G Pirtskhalaishvili","year":"2000","unstructured":"Pirtskhalaishvili G, Shurin GV, Esche C et al. Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br J Cancer 2000; 83:506\u2013513","journal-title":"Br J Cancer"},{"key":"9196_CR9","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/(SICI)1521-4141(199907)29:07<2148::AID-IMMU2148>3.0.CO;2-F","volume":"29","author":"C Esche","year":"1999","unstructured":"Esche C, Gambotto A, Satoh Y et al. CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth. Eur J Immunol 1999; 29:2148\u20132155","journal-title":"Eur J Immunol"},{"key":"9196_CR10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0952-7915(00)00144-8","volume":"12","author":"N Mach","year":"2000","unstructured":"Mach N, Dranoff G. Cytokine-secreting tumor cell vaccines. Curr Opin Immunol 2000; 12:571\u2013575","journal-title":"Curr Opin Immunol"},{"key":"9196_CR11","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/PL00014053","volume":"46 Suppl","author":"WG Nelson","year":"2000","unstructured":"Nelson WG, Simons JW, Mikhak B, et al. Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Cancer Chemotherapy & Pharmacology 2000; 46 Suppl:S67\u2013S72","journal-title":"Cancer Chemotherapy & Pharmacology"},{"key":"9196_CR12","first-page":"1537","volume":"57","author":"JW Simons","year":"1997","unstructured":"Simons JW, Jaffee EM, Weber CE, et al. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res 1997; 57:1537\u20131546","journal-title":"Cancer Res"},{"key":"9196_CR13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/10430340050015455","volume":"11","author":"AE Chang","year":"2000","unstructured":"Chang AE, Li Q, Bishop DK, Normolle DP, Redman BD, Nickoloff BJ. Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor. Hum Gene Ther 2000; 11:839\u2013850","journal-title":"Hum Gene Ther"},{"key":"9196_CR14","first-page":"5160","volume":"59","author":"JW Simons","year":"1999","unstructured":"Simons JW, Mikhak B, Chang JF et al. Induction of Immunity to Prostate Cancer Antigens: Results of a Clinical Trial of Vaccination with Irradiated Autologous Prostate Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor Using ex Vivo Gene Transfer. Cancer Res 1999; 59:5160\u20135168","journal-title":"Cancer Res"},{"key":"9196_CR15","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.95.22.13141","volume":"95","author":"R Soiffer","year":"1998","unstructured":"Soiffer R, Lynch T, Mihm M et al. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. PNAS (USA) 1998; 95:13141\u201313146","journal-title":"PNAS (USA)"},{"key":"9196_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s002620100213","volume":"50","author":"M Kusumoto","year":"2001","unstructured":"Kusumoto M, Umeda S, Ikubo A et al. Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene. Cancer Immunol Immunother 2001; 50:373\u2013381","journal-title":"Cancer Immunol Immunother"},{"key":"9196_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.190.1.125","volume":"190","author":"C Chiodoni","year":"1999","unstructured":"Chiodoni C, Paglia P, Stoppacciaro A, Rodolfo M, Parenza M, Colombo MP. Dendritic cells infiltrating tumors cotransduced with granulocyte\/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J Exp Med 1999; 190:125\u2013133","journal-title":"J Exp Med"},{"key":"9196_CR18","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1089\/10430349950017347","volume":"10","author":"I Borrello","year":"1999","unstructured":"Borrello I, Sotomayor EM, Cooke S, Levitsky HI. A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines. Hum Gene Ther 1999; 10:1983\u20131991","journal-title":"Hum Gene Ther"},{"key":"9196_CR19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood.V100.1.200","volume":"100","author":"G Dotti","year":"2002","unstructured":"Dotti G, Savoldo B, Yotnda P, Rill D, Brenner MK. Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40 (+) and CD40 (-) plasmacytoma cells. Blood 2002; 100:200\u2013207","journal-title":"Blood"},{"key":"9196_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijc.2910230202","volume":"23","author":"LC Andersson","year":"1979","unstructured":"Andersson LC, Nilsson K, Gahmberg CG. K562\u2014a human erythroleukemic cell line. Int J Cancer 1979; 23:143\u2013147","journal-title":"Int J Cancer"},{"key":"9196_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cgt.7700018","volume":"6","author":"S Dessureault","year":"1999","unstructured":"Dessureault S, Graham FL, Gallinger S. Autologous lymphocyte responses to adenovirus-B7-1-transduced human cancer cells. Cancer Gene Ther 1999; 6:195\u2013208","journal-title":"Cancer Gene Ther"},{"key":"9196_CR22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","volume":"184","author":"M Cella","year":"1996","unstructured":"Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184:747\u2013752","journal-title":"J Exp Med"},{"key":"9196_CR23","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1200\/JCO.2005.07.020","volume":"23","author":"LG Salazar","year":"2005","unstructured":"Salazar LG, Disis ML. Cancer vaccines: the role of tumor burden in tipping the scale toward vaccine efficacy. J Clin Oncol 2005; 23:7397\u20137398","journal-title":"J Clin Oncol"},{"key":"9196_CR24","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1200\/JCO.2005.01.6816","volume":"23","author":"RM Luiten","year":"2005","unstructured":"Luiten RM, Kueter EWM, Mooi W et al. Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients. J Clin Oncol 2005; 23:8978\u20138991","journal-title":"J Clin Oncol"},{"key":"9196_CR25","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/1078-0432.CCR-05-2013","volume":"12","author":"SJ Antonia","year":"2006","unstructured":"Antonia SJ, Mirza N, Fricke I, et al. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. Clin Cancer Res 2006; 12:878\u2013887","journal-title":"Clin Cancer Res"},{"key":"9196_CR26","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1158\/1078-0432.CCR-04-2111","volume":"11","author":"JG Gribben","year":"2005","unstructured":"Gribben JG, Ryan DP, Boyajian R et al. Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy. Clin Cancer Res 2005; 11:4430\u20134436","journal-title":"Clin Cancer Res"},{"key":"9196_CR27","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1158\/1078-0432.CCR-04-0497","volume":"10","author":"CJ Wheeler","year":"2004","unstructured":"Wheeler CJ, Das A, Liu G, Yu JS, Black KL. Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin Cancer Res 2004; 10:5316\u20135326","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-006-9196-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-006-9196-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-006-9196-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:23:47Z","timestamp":1572971027000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-006-9196-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,14]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["9196"],"URL":"https:\/\/doi.org\/10.1245\/s10434-006-9196-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,14]]}}}